A Study Of Clinical Implications Of Pulmonary Vascular Disease In Valvular Heart Disease
Recruiting now
Conditions studied: Pulmonary Vascular Disease, Valvular Heart Disease
In brief
The purpose of this study is to characterize pulmonary hemodynamic profiles, with a focus on PVR subtypes, in patients with left-sided valvular heart disease undergoing aortic or mitral valve intervention, and to identify patterns predicting reversibility of TR and RV dysfunction.
Key facts
- Study ID
- NCT07483203
- Run by
- Mayo Clinic
- People needed
- 600
- Starts
- 2026-04-28
- Expected to finish
- 2028-05-01
- Last updated by the study team
- 2026-06-18
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ≥18 years old; AND
- Scheduled for valve procedures
You may not qualify if…
- Congenital heart disease (except for bicuspid aortic valve), OR
- Carcinoid heart disease, OR
- Valvular mass, OR
- Endocarditis, OR
- Any other condition that, in the opinion of the investigator, would impair their ability to complete the study
Where it is running
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.